Download
https://www.ndtvprofit.com/business/biocon-biologics-debt-funded-viatris-deal-spooks-investors?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Shares tumbled after Monday's announcement and closed more than 11.6% lower, the biggest decline in 13 months.
Share